Lv7
4935 积分 2021-06-10 加入
Anti-BCMA/GPRC5D CAR T cells in patients with relapsed or refractory multiple myeloma who have extraosseous extramedullary disease
13小时前
待确认
Phase 3 randomized study of teclistamab plus daratumumab versus investigator’s choice of daratumumab and dexamethasone with either pomalidomide or Bortezomib (DPd/DVd) in patients (Pts) with relapsed refractory multiple myeloma (RRMM): Results of majestec-3
1个月前
已完结
Talquetamab–Daratumumab in Relapsed or Refractory Myeloma
1个月前
已完结
Phase 3 randomized study of teclistamab plus daratumumab versus investigator’s choice of daratumumab and dexamethasone with either pomalidomide or Bortezomib (DPd/DVd) in patients (Pts) with relapsed refractory multiple myeloma (RRMM): Results of majestec-3
1个月前
已完结
Epidemiological patterns of leukaemia in 184 countries: a population-based study
1个月前
已完结
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study
1个月前
已完结
Delay differential equation (DDE) modeling of CAR-T cellular kinetics: Application to BCMA-targeted (Ide-cel, Orva-cel) and CD19-targeted (Lisocel) therapies
1个月前
已完结
Investigating the Influence of Covariates on Axicabtagene Ciloleucel (axi-cel) Kinetics in Patients with Non-Hodgkin’s Lymphoma
1个月前
已完结
Self-Cleaving Protein Linkers with Modulated Ph-Responsiveness: A New Platform for Selective Control of Protein Drug Function
1个月前
已完结
A genetic system yields self-cleaving inteins for bioseparations
1个月前
已完结
皖公网安备34019202002308
